These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. NK4 regulates 5-fluorouracil sensitivity in cholangiocarcinoma cells by modulating the intrinsic apoptosis pathway. Ge X; Wang Y; Li Q; Yu H; Ji G; Miao L Oncol Rep; 2013 Jul; 30(1):448-54. PubMed ID: 23619566 [TBL] [Abstract][Full Text] [Related]
3. Gene transfer of NK4, an angiogenesis inhibitor, induces CT26 tumor regression via tumor-specific T lymphocyte activation. Kubota T; Taiyoh H; Matsumura A; Murayama Y; Ichikawa D; Okamoto K; Fujiwara H; Ikoma H; Nakanishi M; Kikuchi S; Ochiai T; Sakakura C; Kokuba Y; Sonoyama T; Suzuki Y; Matsumoto K; Nakamura T; Otsuji E Int J Cancer; 2009 Dec; 125(12):2879-86. PubMed ID: 19588506 [TBL] [Abstract][Full Text] [Related]
4. Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice. Wen J; Matsumoto K; Taniura N; Tomioka D; Nakamura T Cancer Gene Ther; 2004 Jun; 11(6):419-30. PubMed ID: 15017381 [TBL] [Abstract][Full Text] [Related]
5. [Growth suppression of subcutaneous tumor by CT26 expressing NK4 in syngeneic mice]. Kubota T; Fujiwara H; Amaike H; Takashima K; Inada S; Atsuji K; Yoshimura M; Matsumoto K; Nakamura T; Yamagishi H Gan To Kagaku Ryoho; 2002 Nov; 29(12):2258-60. PubMed ID: 12484049 [TBL] [Abstract][Full Text] [Related]
6. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of colon cancer growth and metastasis by NK4 gene repetitive delivery in mice. Wen J; Matsumoto K; Taniura N; Tomioka D; Nakamura T Biochem Biophys Res Commun; 2007 Jun; 358(1):117-23. PubMed ID: 17467663 [TBL] [Abstract][Full Text] [Related]
8. HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 murine cells. Matsumura A; Kubota T; Taiyoh H; Fujiwara H; Okamoto K; Ichikawa D; Shiozaki A; Komatsu S; Nakanishi M; Kuriu Y; Murayama Y; Ikoma H; Ochiai T; Kokuba Y; Nakamura T; Matsumoto K; Otsuji E Int J Oncol; 2013 Feb; 42(2):535-42. PubMed ID: 23233163 [TBL] [Abstract][Full Text] [Related]
9. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil. Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy. Heideman DA; Overmeer RM; van Beusechem VW; Lamers WH; Hakvoort TB; Snijders PJ; Craanen ME; Offerhaus GJ; Meijer CJ; Gerritsen WR Cancer Gene Ther; 2005 Dec; 12(12):954-62. PubMed ID: 15905856 [TBL] [Abstract][Full Text] [Related]
11. [Effect of transferred NK4 gene on biological characteristics of human pancreatic cancer cell line SW1990]. Lai RX; Yuan SZ; Nakamura T Ai Zheng; 2004 Oct; 23(10):1134-8. PubMed ID: 15473922 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma. Suzuki Y; Sakai K; Ueki J; Xu Q; Nakamura T; Shimada H; Nakamura T; Matsumoto K Int J Cancer; 2010 Oct; 127(8):1948-57. PubMed ID: 20104519 [TBL] [Abstract][Full Text] [Related]
13. NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells. Ge X; Wang Y; Wang Y; Li Q; Yu H; Miao L Dig Dis Sci; 2013 Jun; 58(6):1636-43. PubMed ID: 23314853 [TBL] [Abstract][Full Text] [Related]
14. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4. Heideman DA; van Beusechem VW; Bloemena E; Snijders PJ; Craanen ME; Offerhaus GJ; Derksen PW; de Bruin M; Witlox MA; Molenaar B; Meijer CJ; Gerritsen WR J Gene Med; 2004 Mar; 6(3):317-27. PubMed ID: 15026993 [TBL] [Abstract][Full Text] [Related]
15. Possible inhibition of cancer cell adhesion to the extracellular matrix in NK4-induced suppression of peritoneal implantation. Yoshimura M; Fujiwara H; Kubota T; Amaike H; Takashima K; Inada S; Atsuji K; Araki Y; Matsumoto K; Nakamura T; Yamagishi H Anticancer Res; 2005; 25(6B):3847-54. PubMed ID: 16309170 [TBL] [Abstract][Full Text] [Related]
16. Suppression of heat shock protein 27 expression promotes 5-fluorouracil sensitivity in colon cancer cells in a xenograft model. Hayashi R; Ishii Y; Ochiai H; Matsunaga A; Endo T; Hasegawa H; Kitagawa Y Oncol Rep; 2012 Oct; 28(4):1269-74. PubMed ID: 22842517 [TBL] [Abstract][Full Text] [Related]
17. Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4. Saimura M; Nagai E; Mizumoto K; Maehara N; Minamishima YA; Katano M; Matsumoto K; Nakamura T; Tanaka M Clin Cancer Res; 2002 Oct; 8(10):3243-9. PubMed ID: 12374695 [TBL] [Abstract][Full Text] [Related]
18. Nk4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells. Parr C; Hiscox S; Nakamura T; Matsumoto K; Jiang WG Int J Cancer; 2000 Feb; 85(4):563-70. PubMed ID: 10699931 [TBL] [Abstract][Full Text] [Related]
19. [Effect of NK4 gene transfection on tumor growth of human pancreatic cancer xenograft in nude mice]. Lai RX; Zhang SN; Nakamura T; Yuan SZ Ai Zheng; 2005 Oct; 24(10):1191-5. PubMed ID: 16219131 [TBL] [Abstract][Full Text] [Related]
20. Adenoviral-mediated gene transduction of the hepatocyte growth factor (HGF) antagonist, NK4, suppresses peritoneal metastases of gastric cancer in nude mice. Ueda K; Iwahashi M; Matsuura I; Nakamori M; Nakamura M; Ojima T; Naka T; Ishida K; Matsumoto K; Nakamura T; Yamaue H Eur J Cancer; 2004 Sep; 40(14):2135-42. PubMed ID: 15341989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]